Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPREME: Rivaroxaban for VTE Prophylaxis in AECOPD
NCT03277001Unknown
- Sponsor
- Huashan Hospital
- Start
- Oct 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rivaroxaban in venous thromboembolism (VTE) (2 arms), sponsored by Huashan Hospital. Primary endpoint: Venous Thromboembolism Incidence at 1 month. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03277001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277001.